Glucose-Regulating Drugs Aid COVID-19 Outcomes in Patients With Diabetes
Findings include GLP-1R agonists and pioglitazone use, with drop in hospital admissions
COVID19
D-Dimer Level Not Useful for Ruling Out PE in COVID-19 Patients
Overall, 92.3% of patients had plasma D-dimer levels ≥0.05 µg/mL, including all with and 91.2% without, pulmonary embolism
Outpatient Anticoagulant Therapy May Cut COVID-19 Admission Risk
COVID-19 inpatients not on anticoagulants before or after hospitalization have increased risk for mortality
Disparities Found in Kidney Failure Treatment Early in COVID-19 Pandemic
Disruptions in end-stage kidney disease care disproportionately affected socially disadvantaged populations.
Racial/Ethnic Disparities in Excess Mortality Up During Pandemic
Black, American Indian/Alaska Native, Latino persons also disproportionately affected by non-COVID-19 excess deaths
Study Characterizes Multisystem Inflammatory Syndrome in Adults
Review shows median age of 21 years, involvement of 5 organ systems, and presentation 4 weeks after COVID-19
Health Care Workers Show Greatest COVID-19 Stress
Findings compared to other occupational categories, but across occupations, women had high levels of stress, with age acting as a protective factor
Factors Tied to COVID-19 Severity, Recovery, and Death in Cancer Patients
Non-Caucasian patients had a greater risk of developing severe COVID-19, but Asian patients had a lower risk of death from COVID-19.
DPP-4 Inhibitors Lower COVID-19 Mortality in Patients With Type 2 Diabetes
Investigators aimed to determine the association of pre-existing DPP-4is use with COVID-19–related outcomes among patients with T2DM.
Cancer Patients With COVID-19 Less Likely to Receive Critical Care Despite Higher Risk of Death
Cancer patients were less likely to receive critical care, whether they were on active anticancer treatment or not.
- Loading...
Loading...
Next post in Urology
Loading... 
Loading...